From: A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study
Phenotype | Acronym | Phenotypes | N | h2 * | Offspring Exam | Adjustment†Multivariable model |
---|---|---|---|---|---|---|
Total cholesterol | TC | 7 | 1069 | 0.57‡ | 1,2,3,4,5,6,7 | Age, age2, smoking, body mass index, alcohol consumption, menopausal status, hormone replacement therapy; Covariate-adjusted residuals created separately by gender |
Low-density lipoprotein cholesterol | LDL-C | 7 | 1056 | 0.59‡ | 1,2,3,4,5,6,7 |  |
High-density lipoprotein cholesterol | HDL-C | 7 | 1062 | 0.52‡ | 1,2,3,4,5,6,7 |  |
Triglycerides | TG | 7 | 1068 | 0.48‡ | 1,2,3,4,5,6,7 |  |
Mean total cholesterol | MeanTC | 1 | 1087 | 0.61 | Avg of Exams 1,2,3,4,5,6,7 | Â |
Mean low-density lipoprotein cholesterol | MeanLDL-C | 1 | 1086 | 0.66 | Avg of Exams 1,2,3,4,5,6,7 | Â |
Mean high-density lipoprotein cholesterol | MeanHDL-C | 1 | 1087 | 0.69 | Avg of Exams 1,2,3,4,5,6,7 | Â |
Mean triglycerides | MeanTG | 1 | 1087 | 0.58 | Avg of Exams 1,2,3,4,5,6,7 | Â |
Apolipoprotein A-I | ApoA-I | 1 | 997 | 0.42 | 4 | Â |
Apolipoprotein B | ApoB | 1 | 997 | 0.47 | 4 | Â |
Apolipoprotein C3 | ApoC3 | 1 | 767 | 0.38 | 4 | Â |
Apolipoprotein E | ApoE | 1 | 744 | 0.54 | 5 | Â |
High-density lipoprotein 2 cholesterol | HDL2-C | 2 | 955 (exam 4) 958 (exam 5) | 0.50 0.53 | 4,5 | Â |
High-density lipoprotein 3 cholesterol | HDL3-C | 2 | 984 (exam 4) 1020 (exam 5) | 0.48 0.54 | 4,5 | Â |
Large high-density lipoprotein by NMR | HDLNMRlg | 1 | 851 | 0.53 | 4 | Â |
Intermediate high-density lipoprotein by NMR | HDLNMRint | 1 | 851 | 0.22 | 4 | Â |
Small high-density lipoprotein by NMR | HDLNMRsm | 1 | 851 | 0.24 | 4 | Â |
High-density lipoprotein particle size by NMR | HDLNMRsz | 1 | 851 | 0.50 | 4 | Â |
Intermediate-density lipoprotein particle by NMR | IDLNMR | 1 | 851 | 0.20 | 4 | Â |
Large low-density lipoprotein by NMR | LDLNMRlg | 1 | 851 | 0.39 | 4 | Â |
Small low-density lipoprotein by NMR | LDLNMRsm | 1 | 851 | 0.40 | 4 | Â |
Low-density lipoprotein particle size by NMR | LDLNMRsz | 1 | 851 | 0.40 | 4 | Â |
Large very low-density lipoprotein particle by NMR | VLDLNMRlg | 1 | 851 | 0.34 | 4 | Â |
Intermediate very low-density lipoprotein particle by NMR | VLDLNMRint | 1 | 878 | 0.40 | 4 | Â |
Small very low-density lipoprotein particle by NMR | VLDLNMRsm | 1 | 851 | 0.24 | 4 | Â |
Very low-density lipoprotein particle size by NMR | VLDLNMRsz | 1 | 851 | 0.42 | 4 | Â |
Triglyceride/high-density lipoprotein cholesterol ratio | tghdl | 7 | 1060 | 0.56‡ | 1,2,3,4,5,6,7 |  |
Total cholesterol/high-density lipoprotein cholesterol ratio | cholhdl | 7 | 1060 | 0.58‡ | 1,2,3,4,5,6,7 |  |
Lipoprotein(a) | Lp(a) | 1 | 763 | 0.90 | 3 | Â |
Remnant lipoprotein cholesterol | RLP-C | 1 | 746 | 0.34 | 4 | Â |
Remnant lipoprotein triglycerides | RLP-TG | 1 | 715 | 0.33 | 4 | Â |